Product Information

METHYLPHENIDATE ER(LA) 20 MG CP is a generic product labeled by Granules Pharmaceuticals Inc., priced at $1.4763 per EA under NDC 70010001301. Its NADAC has been published 364 times since Dec 4, 2019.

FDA first approved this application on May 23, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE ER(LA) 20 MG CP

Methylphenidate Hydrochloride
$1.4763per EA
DEA Schedule CII

Strength

20 mg/1

NDC

70010001301

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211796

FDA Approved

5/23/2019

TE Code

AB1

On Market Since

9/10/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER(LA) 20 MG CP has been published 364 times since Dec 4, 2019, and over the history we have for it it has declined 57.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4763 per EA
All-time high$4.0406 (Jan 15, 2020)
All-time low$1.0595 (Sep 22, 2021)
52-week high$2.0362
52-week low$1.4763
Median price$1.8267
Average price$1.9171
Largest weekly change+60.7% (Aug 21, 2024)
Weeks tracked364
Tracking sinceDec 4, 2019

Price History

1W

-8.6%

1M

-12.9%

3M

-18.5%

6M

-21.1%

1Y

-21.4%

3Y

-18.3%

5Y

+8.4%

All

-57.8%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER(LA) 20 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(LA) 20 MG CP, manufactured by Granules Pharmaceuticals Inc., is $1.4763 per EA (NDC 70010001301), effective Nov 18, 2026.

How has the price of METHYLPHENIDATE ER(LA) 20 MG CP changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER(LA) 20 MG CP has declined 57.8%. It has been tracked across 364 weekly CMS publications since Dec 4, 2019.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(LA) 20 MG CP?

Since Dec 4, 2019, the NADAC for METHYLPHENIDATE ER(LA) 20 MG CP has ranged from a low of $1.0595 (Sep 22, 2021) to a high of $4.0406 (Jan 15, 2020), with a median of $1.8267 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER(LA) 20 MG CP?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER(LA) 20 MG CP in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPHENIDATE ER(LA) 20 MG CP?

METHYLPHENIDATE ER(LA) 20 MG CP (NDC 70010001301) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.